Legacy Education's Shrinking Growth Rate Puts Student Starts And Houston Launch On Trial

For most of fiscal 2026, Legacy Education was a growth story powered by an acquisition and a wave of new programs. The September quarter is the first real look at what the business looks like once that tailwind fades. Wall Street expects revenue of about $20.2 million, only 4.1% above the $19.4 million posted a year ago, and earnings of $0.15 per share, down 6.3% from $0.16. That is a sharp step down from the 12% revenue growth of the June quarter and the roughly 40% pace of the first half. The question is whether the slowdown is a pause before new programs and a Texas campus kick in, or something more lasting.

The company has not offered formal guidance, so the best roadmap is what management said last quarter. Executives signaled that new student starts in the September quarter would look roughly like June, when they fell about 4% year over year after a roughly 12% drop in the March quarter. Starts are the leading indicator for a school operator because they feed future enrollment and tuition revenue. A third straight negative print would be expected, but its size matters. A decline in the low single digits would support the view that the trough is near. A deeper drop would suggest the headwinds management cited, including tighter vocational nursing entrance requirements and a slow sterile processing ramp, are biting harder than advertised. Ending student population, which grew just 8.9% at fiscal year-end versus nearly 38% at the start of the year, is the companion figure to watch.

Profitability is the other half of the test. Consensus implies earnings rising from $0.13 last quarter to $0.15 on essentially flat sequential revenue, which assumes some margin recovery. That is not a given. Educational services expense climbed to 56% of revenue in the June quarter from 52.6% a year earlier as Legacy spent on capacity ahead of enrollment. The CFO expects margins to expand in fiscal 2027 but weighted toward the second half, so modest pressure now would not break the story. Costs continuing to outrun revenue, however, especially with Houston start-up spending arriving, would make the back-half recovery harder to believe.

Several catalysts are due for updates. Surgical technology was supposed to launch at a third High Desert Medical College campus by the end of this quarter after slipping on lab and equipment readiness, and the Houston branch, a 28,000 square foot site targeting a November 2026 opening pending approvals, should be at or near launch by the time results arrive. Confirmation that approvals are in hand and early enrollment is building would give real weight to management's estimate of 400 to 600 students within a year or two. The long-promised acquisition, which missed its fiscal 2026 target, needs either a concrete deal or a credible explanation. Cash conversion also deserves attention after operating cash flow of just $4 million trailed $9.1 million of net income as receivables swelled.

The mood has improved somewhat. Sentiment remains bearish but far less so than before the last report, and the shares have gained 1.8% since then while the S&P 500 slipped 1.9%. Still, at $9.42 the stock sits well below its 200-day average of $11.41 and in the lower half of a post-earnings range of $8.53 to $10.59, a band that sits entirely beneath the prior quarter's $10.00 to $12.60. The market has steadied but not re-rated the shares.

Ultimately, this report hinges on whether starts are stabilizing as promised. If enrollment trends flatten, costs hold steady and Houston opens on schedule, the slowdown looks like a digestion phase ahead of renewed growth. If starts slide further while expenses climb, the recovery case shifts almost entirely onto a new campus that has yet to enroll a student.

This earnings preview was originally published on Earnings Whispers.

This article is for informational purposes only and is not investment advice. Earnings Whispers and its staff may hold positions in the securities mentioned. It is AI-assisted, based on proprietary Earnings Whispers data and company reports, and edited by Earnings Whispers staff.